130 related articles for article (PubMed ID: 38783480)
1. Study of the Conformational Dynamics of Prolyl Oligopeptidase by Mass Spectrometry: Lessons Learned.
Van Elzen R; Konijnenberg A; Van der Veken P; Edgeworth MJ; Scrivens JH; Fülöp V; Sobott F; Lambeir AM
J Med Chem; 2024 Jun; 67(12):10436-10446. PubMed ID: 38783480
[TBL] [Abstract][Full Text] [Related]
2. Analyzing slowly exchanging protein conformations by ion mobility mass spectrometry: study of the dynamic equilibrium of prolyl oligopeptidase.
López A; Vilaseca M; Madurga S; Varese M; Tarragó T; Giralt E
J Mass Spectrom; 2016 Jul; 51(7):504-11. PubMed ID: 27434808
[TBL] [Abstract][Full Text] [Related]
3. Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometry.
Tsirigotaki A; Elzen RV; Veken PV; Lambeir AM; Economou A
Sci Rep; 2017 May; 7(1):2456. PubMed ID: 28550305
[TBL] [Abstract][Full Text] [Related]
4. Crystal Structure and Conformational Dynamics of Pyrococcus furiosus Prolyl Oligopeptidase.
Ellis-Guardiola K; Rui H; Beckner RL; Srivastava P; Sukumar N; Roux B; Lewis JC
Biochemistry; 2019 Mar; 58(12):1616-1626. PubMed ID: 30786206
[TBL] [Abstract][Full Text] [Related]
5. Ion mobility-mass spectrometry as a tool to investigate protein-ligand interactions.
Göth M; Pagel K
Anal Bioanal Chem; 2017 Jul; 409(18):4305-4310. PubMed ID: 28500372
[TBL] [Abstract][Full Text] [Related]
6. The prolyl oligopeptidase family.
Polgár L
Cell Mol Life Sci; 2002 Feb; 59(2):349-62. PubMed ID: 11915948
[TBL] [Abstract][Full Text] [Related]
7. Ion mobility coupled to native mass spectrometry as a relevant tool to investigate extremely small ligand-induced conformational changes.
Stojko J; Fieulaine S; Petiot-Bécard S; Van Dorsselaer A; Meinnel T; Giglione C; Cianférani S
Analyst; 2015 Nov; 140(21):7234-45. PubMed ID: 26401526
[TBL] [Abstract][Full Text] [Related]
8. The PREPL A protein, a new member of the prolyl oligopeptidase family, lacking catalytic activity.
Szeltner Z; Alshafee I; Juhász T; Parvari R; Polgár L
Cell Mol Life Sci; 2005 Oct; 62(19-20):2376-81. PubMed ID: 16143824
[TBL] [Abstract][Full Text] [Related]
9. Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics.
López A; Herranz-Trillo F; Kotev M; Gairí M; Guallar V; Bernadó P; Millet O; Tarragó T; Giralt E
Chembiochem; 2016 May; 17(10):913-7. PubMed ID: 26918396
[TBL] [Abstract][Full Text] [Related]
10. Structures of prolyl oligopeptidase substrate/inhibitor complexes. Use of inhibitor binding for titration of the catalytic histidine residue.
Fülöp V; Szeltner Z; Renner V; Polgár L
J Biol Chem; 2001 Jan; 276(2):1262-6. PubMed ID: 11031266
[TBL] [Abstract][Full Text] [Related]
11. Screening, purification, and characterization of an extracellular prolyl oligopeptidase from Coprinopsis clastophylla.
Chen JT; Chao ML; Wen CY; Chu WS
J Microbiol; 2012 Aug; 50(4):652-9. PubMed ID: 22923115
[TBL] [Abstract][Full Text] [Related]
12. 5-Aminothiazoles Reveal a New Ligand-Binding Site on Prolyl Oligopeptidase Which is Important for Modulation of Its Protein-Protein Interaction-Derived Functions.
Pätsi HT; Kilpeläinen TP; Jumppanen M; Uhari-Väänänen J; Wielendaele PV; De Lorenzo F; Cui H; Auno S; Saharinen J; Seppälä E; Sipari N; Savinainen J; De Meester I; Lambeir AM; Lahtela-Kakkonen M; Myöhänen TT; Wallén EAA
J Med Chem; 2024 Apr; 67(7):5421-5436. PubMed ID: 38546708
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of prolyl oligopeptidases using molecular docking and dynamics: insights into conformational changes and ligand binding.
Kaushik S; Sowdhamini R
PLoS One; 2011; 6(11):e26251. PubMed ID: 22132071
[TBL] [Abstract][Full Text] [Related]
14. Ion Mobility-Mass Spectrometry to Evaluate the Effects of Protein Modification or Small Molecule Binding on Protein Dynamics.
Tomlinson LJ; Eyers CE
Methods Mol Biol; 2020; 2084():179-190. PubMed ID: 31729661
[TBL] [Abstract][Full Text] [Related]
15. Native Mass Spectrometry, Ion Mobility, and Collision-Induced Unfolding for Conformational Characterization of IgG4 Monoclonal Antibodies.
Hernandez-Alba O; Wagner-Rousset E; Beck A; Cianférani S
Anal Chem; 2018 Aug; 90(15):8865-8872. PubMed ID: 29956914
[TBL] [Abstract][Full Text] [Related]
16. Cleavage of the Lys196-Ser197 bond of prolyl oligopeptidase: enhanced catalytic activity for one of the two active enzyme forms.
Polgár L; Patthy A
Biochemistry; 1992 Nov; 31(44):10769-73. PubMed ID: 1420194
[TBL] [Abstract][Full Text] [Related]
17. The noncatalytic beta-propeller domain of prolyl oligopeptidase enhances the catalytic capability of the peptidase domain.
Szeltner Z; Renner V; Polgár L
J Biol Chem; 2000 May; 275(20):15000-5. PubMed ID: 10747969
[TBL] [Abstract][Full Text] [Related]
18. An integrative approach combining ion mobility mass spectrometry, X-ray crystallography, and nuclear magnetic resonance spectroscopy to study the conformational dynamics of α1 -antitrypsin upon ligand binding.
Nyon MP; Prentice T; Day J; Kirkpatrick J; Sivalingam GN; Levy G; Haq I; Irving JA; Lomas DA; Christodoulou J; Gooptu B; Thalassinos K
Protein Sci; 2015 Aug; 24(8):1301-12. PubMed ID: 26011795
[TBL] [Abstract][Full Text] [Related]
19. Low barrier hydrogen bond is absent in the catalytic triads in the ground state but Is present in a transition-state complex in the prolyl oligopeptidase family of serine proteases.
Kahyaoglu A; Haghjoo K; Guo F; Jordan F; Kettner C; Felföldi F; Polgár L
J Biol Chem; 1997 Oct; 272(41):25547-54. PubMed ID: 9325271
[TBL] [Abstract][Full Text] [Related]
20. The purification, characterization and analysis of primary and secondary-structure of prolyl oligopeptidase from human lymphocytes. Evidence that the enzyme belongs to the alpha/beta hydrolase fold family.
Goossens F; De Meester I; Vanhoof G; Hendriks D; Vriend G; Scharpé S
Eur J Biochem; 1995 Oct; 233(2):432-41. PubMed ID: 7588785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
